Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 11, 2017 - Issue 4
Submit an article Journal homepage
819
Views
39
CrossRef citations to date
0
Altmetric
Review

Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the ‘bed’ that counts and not ‘the sleepers’

Ioannis P. TomosRespiratory Medicine Department, ‘Attikon’ University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, GreeceView further author information
,
Argyrios TzouvelekisDivision of Immunology, Biomedical Sciences Research Center ‘Alexander Fleming,’, Athens, GreeceView further author information
,
Vassilis AidinisDivision of Immunology, Biomedical Sciences Research Center ‘Alexander Fleming,’, Athens, GreeceView further author information
,
Effrosyni D. ManaliRespiratory Medicine Department, ‘Attikon’ University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, GreeceView further author information
,
Evangelos BourosFirst Academic Department of Pneumonology, Hospital for Diseases of the Chest, ‘Sotiria,’ Medical School, National and Kapodistrian University of Athens, Athens, GreeceView further author information
,
Demosthenes BourosFirst Academic Department of Pneumonology, Hospital for Diseases of the Chest, ‘Sotiria,’ Medical School, National and Kapodistrian University of Athens, Athens, GreeceView further author information
&
Spyros A. PapirisRespiratory Medicine Department, ‘Attikon’ University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens, GreeceCorrespondence[email protected]
View further author information
 show all
Pages 299-309 | Received 30 Nov 2016, Accepted 24 Feb 2017, Published online: 08 Mar 2017

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ye-Li Zhao, Xuan Zhang, Wei-Wei Liu, Yu-Ting Yang, Zhuo-Kun Gao, Xiao-Ling Liu, Wei Liu, Toshihiko Hayashi, Masayuki Yamato, Hitomi Fujisaki, Shunji Hattori, Kazunori Mizuno, Yuji Atsuzawa, Shin-ichi Tashiro, Satoshi Onodera & Takashi Ikejima. (2019) Reactive oxygen species are responsible for the cell aggregation and production of pro-inflammatory mediators in phorbol ester (PMA)-treated U937 cells on gelatin-coated dishes through upregulation of autophagy. Connective Tissue Research 60:4, pages 323-334.
Read now

Articles from other publishers (38)

Fama Thiam, Sakshi Phogat, Filsan Ahmed Abokor & Emmanuel Twumasi Osei. (2023) In vitro co-culture studies and the crucial role of fibroblast-immune cell crosstalk in IPF pathogenesis. Respiratory Research 24:1.
Crossref
J. Brussow, K. Feng, F. Thiam, S. Phogat & E.T. Osei. (2023) Epithelial-fibroblast interactions in IPF: Lessons from in vitro co-culture studies. Differentiation 134, pages 11-19.
Crossref
Hong Luo, Jisong Yan & Xia Zhou. (2023) Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning. BMC Pulmonary Medicine 23:1.
Crossref
Ioannis Tomos, Ioannis Roussis, Andreas M. Matthaiou & Katerina Dimakou. (2023) Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?. Biomedicines 11:10, pages 2796.
Crossref
Richard J. Hewitt, Franz Puttur, David C. A. Gaboriau, Frédéric Fercoq, Maryline Fresquet, William J. Traves, Laura L. Yates, Simone A. Walker, Philip L. Molyneaux, Samuel V. Kemp, Andrew G. Nicholson, Alexandra Rice, Edward Roberts, Rachel Lennon, Leo M. Carlin, Adam J. Byrne, Toby M. Maher & Clare M. Lloyd. (2023) Lung extracellular matrix modulates KRT5+ basal cell activity in pulmonary fibrosis. Nature Communications 14:1.
Crossref
Mingchen Xu, Chenghe Zhao, Haiming Song, Chunmei Wang, He Li, Xudong Qiu, He Jing & Wenyue Zhuang. (2023) Inhibitory effects of Schisandrin C on collagen behavior in pulmonary fibrosis. Scientific Reports 13:1.
Crossref
Yufeng Zhang, Cong Wang, Qingqing Xia, Weilong Jiang, Huizhe Zhang, Ehsan Amiri-Ardekani, Haibing Hua & Yi Cheng. (2023) Machine learning-based prediction of candidate gene biomarkers correlated with immune infiltration in patients with idiopathic pulmonary fibrosis. Frontiers in Medicine 10.
Crossref
Axelle Septembre-Malaterre, Chailas Boina, Audrey Douanier & Philippe Gasque. (2022) Deciphering the Antifibrotic Property of Metformin. Cells 11:24, pages 4090.
Crossref
Spyros A. Papiris, Caroline Kannengiesser, Raphael Borie, Lykourgos Kolilekas, Maria Kallieri, Vasiliki Apollonatou, Ibrahima Ba, Nadia Nathan, Andrew Bush, Matthias Griese, Philippe Dieude, Bruno Crestani & Effrosyni D. Manali. (2022) Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective. Diagnostics 12:12, pages 2928.
Crossref
Huihui Wang, Xiaoxi Wang, Huixing Xu, Xin Wang, Guixin Tang, Yanli Meng & Weiming Wang. (2022) The effect of Wogonoside on the expression of TGF-β1/Smad3 in Mycoplasma pneumoniae pneumonia. Pharmacological Research - Modern Chinese Medicine 2, pages 100018.
Crossref
Apoorva Pandey, Ritu Kulshrestha & Surendra Kumar Bansal. (2021) Dynamic role of LMW-hyaluronan fragments and Toll-like receptors 2,4 in progression of bleomycin induced lung parenchymal injury to fibrosis. The Egyptian Journal of Bronchology 15:1.
Crossref
Jennifer Maries Go Yap, Takashi Ueda, Yoshihiro Kanemitsu, Norihisa Takeda, Kensuke Fukumitsu, Satoshi Fukuda, Takehiro Uemura, Tomoko Tajiri, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Testsuya Oguri, Shinya Ugawa & Akio Niimi. (2021) AITC inhibits fibroblast-myofibroblast transition via TRPA1-independent MAPK and NRF2/HO-1 pathways and reverses corticosteroids insensitivity in human lung fibroblasts. Respiratory Research 22:1.
Crossref
Dong Wang, Lili Gong, Zifa Li, Haihong Chen, Mengzhen Xu, Rong Rong, Yingying Zhang & Qingjun Zhu. (2021) Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis. Journal of Ethnopharmacology 281, pages 114522.
Crossref
Gwenda F. Vasse, Lisette Van Os, Marina De Jager, Marnix R. Jonker, Theo Borghuis, L. Tim Van Den Toorn, Pytrick Jellema, Eric S. White, Patrick Van Rijn, Martin C. Harmsen, Irene H. Heijink, Barbro N. Melgert & Janette K. Burgess. (2021) Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices. Frontiers in Pharmacology 12.
Crossref
Jade Jaffar, Ian Glaspole, Karen Symons & Glen Westall. (2021) Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis. Biomedicine & Pharmacotherapy 138, pages 111471.
Crossref
Paschalis Ntolios, Vassilios Tzilas, Evangelos Bouros, Eleni Avdoula, Ioannis Karakasiliotis, Demosthenes Bouros & Paschalis Steiropoulos. (2021) The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis. Biomedicines 9:4, pages 442.
Crossref
Smriti Mishra, Mohammad Imran Shah, S. Udhaya Kumar, D. Thirumal Kumar, Chandrasekhar Gopalakrishnan, Abeer Mohammed Al-Subaie, R. Magesh, C. George Priya Doss & Balu Kamaraj. 2021. 241 273 .
Yuansheng Gao & J. Usha Raj. 2011. Comprehensive Physiology. Comprehensive Physiology 1351 1369 .
Qun Lv, Jianjun Wang, Changqing Xu, Xuqing Huang, Zhaoyang Ruan & Yifan Dai. (2020) Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways. Molecular Medicine 26:1.
Crossref
Yang Liu & Yongchao Qi. (2020) Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix. International Immunopharmacology 87, pages 106774.
Crossref
Paschalis Ntolios, Paschalis Steiropoulos, Georgia Karpathiou, Stavros Anevlavis, Theodoros Karampitsakos, Evangelos Bouros, Marios E. Froudarakis, Demosthenes Bouros & Argyrios Tzouvelekis. (2020) Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date. BioDrugs 34:5, pages 543-556.
Crossref
Punithavathi Durairaj, Santosh Venkatesan, Venkatesan Narayanan & Mary Babu. (2020) Protective effects of curcumin on bleomycin-induced changes in lung glycoproteins. Molecular and Cellular Biochemistry 469:1-2, pages 159-167.
Crossref
Eva Otoupalova, Sam Smith, Guangjie Cheng & Victor J. Thannickal. 2011. Comprehensive Physiology. Comprehensive Physiology 509 547 .
Li Gao, Dingyuan Jiang, Jing Geng, Run Dong & Huaping Dai. (2019) Hydrogen inhalation attenuated bleomycin‐induced pulmonary fibrosis by inhibiting transforming growth factor‐β1 and relevant oxidative stress and epithelial‐to‐mesenchymal transition. Experimental Physiology 104:12, pages 1942-1951.
Crossref
Abdelaziz Ghanemi, Aicha Melouane, Mayumi Yoshioka & Jonny St-Amand. (2019) Secreted protein acidic and rich in cysteine and bioenergetics: Extracellular matrix, adipocytes remodeling and skeletal muscle metabolism. The International Journal of Biochemistry & Cell Biology 117, pages 105627.
Crossref
M.I. Gumeniuk. (2019) Comorbid Metabolic Disorders in Chronic Lung Diseases. Infusion & Chemotherapy:3, pages 5-15.
Crossref
Yoshinori Tanino, Xintao Wang, Takefumi Nikaido, Kenichi Misa, Yuki Sato, Ryuichi Togawa, Takaya Kawamata, Masami Kikuchi, Charles W. Frevert, Mishie Tanino, Tetsuhito Kojima & Yoko Shibata. (2019) Syndecan-4 Inhibits the Development of Pulmonary Fibrosis by Attenuating TGF-β Signaling. International Journal of Molecular Sciences 20:20, pages 4989.
Crossref
Henrique Bregolin Dias, Jarbas Rodrigues de Oliveira, Márcio Vinícius Fagundes Donadio & Shioko Kimura. (2019) Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts. PLOS ONE 14:9, pages e0222202.
Crossref
Gregoire Ruffenach, Soban Umar, Mylene Vaillancourt, Jason Hong, Nancy Cao, Shervin Sarji, Shayan Moazeni, Christine M Cunningham, Abbas Ardehali, Srinivasa T Reddy, Rajan Saggar, Gregory Fishbein & Mansoureh Eghbali. (2019) Histological hallmarks and role of Slug/ PIP axis in pulmonary hypertension secondary to pulmonary fibrosis . EMBO Molecular Medicine 11:9.
Crossref
Yunjuan Nie, Kaikai Yu, Boyu Li, Yudong Hu, Hui Zhang, Ruiting Xin, Yue Xiong, Peng Zhao & Gaoshang Chai. (2019) S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice. Journal of Pharmacological Sciences 139:4, pages 377-384.
Crossref
Christopher Lambers, Panja M. Boehm, Yasemin Karabacak, Eslam Samaha, Alberto Benazzo, Peter Jaksch & Michael Roth. (2019) Combined Activation of Guanylate Cyclase and Cyclic AMP in Lung Fibroblasts as a Novel Therapeutic Concept for Lung Fibrosis. BioMed Research International 2019, pages 1-10.
Crossref
Janna C. Nawroth, Riccardo Barrile, David Conegliano, Sander van Riet, Pieter S. Hiemstra & Remi Villenave. (2019) Stem cell-based Lung-on-Chips: The best of both worlds?. Advanced Drug Delivery Reviews 140, pages 12-32.
Crossref
Changjun Xu, Pengfei Wang, Chang Lin, Zhu Luo, Yawei Huang, Zongjiang Zhao & Changfu Yang. (2018) The protective and therapeutic effects of total flavonoids of Astragalus against bleomycin-induced pulmonary fibrosis are through the enhancement of autophagy. Journal of Traditional Chinese Medical Sciences 5:4, pages 380-389.
Crossref
Duong Thi Bich Thuan, Hatem Zayed, Ali H. Eid, Haissam Abou-Saleh, Gheyath K. Nasrallah, Arduino A. Mangoni & Gianfranco Pintus. (2018) A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic Sclerosis. Frontiers in Immunology 9.
Crossref
Thomas Divya, Bakthavatchalam Velavan & Ganapasam Sudhandiran. (2018) Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis. Basic & Clinical Pharmacology & Toxicology 123:2, pages 122-129.
Crossref
Argyrios Tzouvelekis, Rebecca Toonkel, Theodoros Karampitsakos, Kantha Medapalli, Ioanna Ninou, Vasilis Aidinis, Demosthenes Bouros & Marilyn K. Glassberg. (2018) Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis. Frontiers in Medicine 5.
Crossref
Argyrios Tzouvelekis, Theodoros Karampitsakos, Maria Kontou, Andreas Granitsas, Ioanna Malliou, Aris Anagnostopoulos, Paschalis Ntolios, Vasilios Tzilas, Evangelos Bouros, Paschalis Steiropoulos, Serafeim Chrysikos, Katerina Dimakou, Nikolaos Koulouris & Demosthenes Bouros. (2018) Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece. Pulmonary Pharmacology & Therapeutics 49, pages 61-66.
Crossref
Ourania Papaioannou, Theodoros Karampitsakos, Ilianna Barbayianni, Serafeim Chrysikos, Nikos Xylourgidis, Vasilis Tzilas, Demosthenes Bouros, Vasilis Aidinis & Argyrios Tzouvelekis. (2018) Metabolic Disorders in Chronic Lung Diseases. Frontiers in Medicine 4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.